Human EGFR/ErbB-1/HER1 Monoclonal Antibody (YR0062)

Basic Information

Clone	Panitumumab Biosimilar
Molecular Weight	150 kDa
Endotoxin	<1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay
Sterility	0.2 μm filtration
Aggregation	<5% Determined by SECP
Purity	>95% Determined by SDS-PAGE

Product Information

Production	Purified from cell culture supernatant in an animal-free facility
Purification	Protein A or G purification
Storage	2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)

Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".

Immunogen Information

Isotype	Human IgG2 kappa
Immunogen	Human EGFR / ErbB-1 / HER1
RecommendedIsotype Control(s)	In Vivo Grade Recombinant Human IgG2 Kappa Isotype Control Antibody
Recommended Dilution Buffer	1×PBS pH 7.0

* For research use only. Not for therapeutic or diagnostic purposes.